Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.26 trillion and total revenue of $115.82 billion.
Market Cap
1.26T
Revenue
115.82B
Profits
-36.12B
PE Ratio
n/a
Profit Margin
-31.19%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 129.25B | 1.33% | 390,434 | 12.59B |
| 2 | MRNA | Moderna, Inc. | 86.14B | 9.52% | 15,842,266 | 2.23B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 74.66B | 1.10% | 141,130 | 15.53B |
| 4 | ARGX | argenx SE | 49.44B | 0.05% | 285,549 | 5.32B |
| 5 | RVMD | Revolution Medicines, Inc. | 40.90B | 1.43% | 902,422 | - |
| 6 | ONC | BeOne Medicines AG | 40.49B | 1.71% | 68,295 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 32.52B | 0.63% | 870,023 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.97B | 3.10% | 330,810 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 25.12B | 1.64% | 820,274 | 7.53M |
| 10 | BNTX | BioNTech SE | 23.98B | 3.71% | 579,124 | 3.03B |
| 11 | INCY | Incyte Corporation | 22.94B | 0.39% | 338,618 | 5.82B |
| 12 | INSM | Insmed Incorporated | 21.94B | -0.03% | 793,565 | 1.14B |
| 13 | GMAB | Genmab A/S | 21.67B | 2.72% | 1,104,648 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 15.01B | 2.63% | 323,285 | 1.20B |
| 15 | EXEL | Exelixis, Inc. | 14.88B | 1.75% | 775,155 | 2.44B |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 14.27B | -1.17% | 513,727 | 4.60B |
| 17 | SMMT | Summit Therapeutics Inc. | 13.86B | 0.93% | 2,837,654 | - |
| 18 | CORT | Corcept Therapeutics Incorporated | 13.04B | 1.73% | 143,231 | 830.81M |
| 19 | BBIO | BridgeBio Pharma, Inc. | 12.75B | 0.26% | 657,357 | 713.07M |
| 20 | HALO | Halozyme Therapeutics, Inc. | 12.69B | 1.76% | 398,696 | 1.66B |
| 21 | TECH | Bio-Techne Corporation | 11.36B | - | 1,035,856 | 1.22B |
| 22 | IBRX | ImmunityBio, Inc. | 11.22B | 6.86% | 9,343,932 | 165.79M |
| 23 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.00B | -0.19% | 129,168 | 1.28B |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 10.59B | -0.36% | 515,586 | 3.41B |
| 25 | PCVX | Vaxcyte, Inc. | 10.40B | 7.50% | 1,347,203 | - |
| 26 | TWST | Twist Bioscience Corporation | 10.17B | 6.66% | 1,848,867 | 431.80M |
| 27 | KRYS | Krystal Biotech, Inc. | 9.80B | 1.16% | 70,803 | 440.48M |
| 28 | KYMR | Kymera Therapeutics, Inc. | 9.45B | 3.95% | 337,929 | 105.00M |
| 29 | PTGX | Protagonist Therapeutics, Inc. | 9.36B | 3.42% | 312,259 | 281.99M |
| 30 | AXSM | Axsome Therapeutics, Inc. | 8.90B | -0.05% | 236,558 | 776.57M |
| 31 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.82B | 2.80% | 425,898 | 669.50M |
| 32 | CYTK | Cytokinetics, Incorporated | 8.70B | 0.97% | 317,537 | 67.67M |
| 33 | CAI | Caris Life Sciences, Inc. | 8.20B | 5.53% | 1,568,406 | 989.61M |
| 34 | SYRE | Spyre Therapeutics, Inc. | 7.92B | 6.07% | 405,739 | - |
| 35 | TGTX | TG Therapeutics, Inc. | 7.82B | 3.30% | 463,454 | 799.54M |
| 36 | IONS | Ionis Pharmaceuticals, Inc. | 7.57B | 5.25% | 1,703,035 | 874.09M |
| 37 | ABVX | ABIVAX Société Anonyme | 7.43B | -1.27% | 441,958 | 5.33M |
| 38 | PRAX | Praxis Precision Medicines, Inc. | 7.38B | 0.29% | 232,784 | 7.46M |
| 39 | IOVA | Iovance Biotherapeutics, Inc. | 6.57B | 8.90% | 8,092,124 | 324.97M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.33B | 2.52% | 615,234 | 239.92M |
| 41 | IMVT | Immunovant, Inc. | 6.27B | 0.36% | 453,682 | - |
| 42 | KOD | Kodiak Sciences Inc. | 6.21B | 5.04% | 536,573 | - |
| 43 | BLTE | Belite Bio, Inc | 6.20B | 0.87% | 51,896 | - |
| 44 | LGND | Ligand Pharmaceuticals Incorporated | 5.95B | 1.14% | 36,571 | 290.54M |
| 45 | CGON | CG Oncology, Inc. | 5.75B | 2.58% | 135,401 | 6.23M |
| 46 | MIRM | Mirum Pharmaceuticals, Inc. | 5.60B | 6.10% | 350,576 | 618.07M |
| 47 | MANE | Veradermics, Incorporated | 5.52B | 4.34% | 409,341 | - |
| 48 | ERAS | Erasca, Inc. | 5.45B | 0.84% | 2,946,236 | - |
| 49 | ORKA | Oruka Therapeutics, Inc. | 5.38B | 5.12% | 457,508 | - |
| 50 | PTCT | PTC Therapeutics, Inc. | 5.30B | 1.46% | 241,891 | 1.01B |
| 51 | COGT | Cogent Biosciences, Inc. | 5.29B | 1.33% | 774,412 | - |
| 52 | SRRK | Scholar Rock Holding Corporation | 5.18B | 0.83% | 345,457 | - |
| 53 | CRSP | CRISPR Therapeutics AG | 5.15B | 5.56% | 727,397 | 13.39M |
| 54 | DFTX | Definium Therapeutics, Inc. | 5.00B | 8.81% | 1,016,340 | - |
| 55 | TVTX | Travere Therapeutics, Inc. | 4.94B | 0.81% | 318,400 | 591.33M |
| 56 | DNTH | Dianthus Therapeutics, Inc. | 4.69B | 1.71% | 201,423 | 1.90M |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 4.27B | 0.28% | 276,993 | - |
| 58 | ABCL | AbCellera Biologics Inc. | 4.08B | 4.78% | 2,369,698 | 66.17M |
| 59 | TNGX | Tango Therapeutics, Inc. | 3.99B | 4.74% | 1,024,533 | 53.81M |
| 60 | RLAY | Relay Therapeutics, Inc. | 3.96B | 3.70% | 438,305 | 10.35M |
| 61 | TLX | Telix Pharmaceuticals Limited | 3.82B | 1.86% | 93,088 | 890.79M |
| 62 | LEGN | Legend Biotech Corporation | 3.66B | 0.94% | 454,694 | 1.27B |
| 63 | PBLS | Parabilis Medicines, Inc. | 3.55B | 2.26% | 315,407 | 148.00K |
| 64 | XENE | Xenon Pharmaceuticals Inc. | 3.52B | 0.44% | 286,377 | 7.50M |
| 65 | IDYA | IDEAYA Biosciences, Inc. | 3.48B | 0.03% | 290,205 | 234.13M |
| 66 | ACAD | Acadia Pharmaceuticals Inc. | 3.42B | 1.43% | 464,781 | 1.14B |
| 67 | VKTX | Viking Therapeutics, Inc. | 3.34B | 3.35% | 2,432,607 | - |
| 68 | ARQT | Arcutis Biotherapeutics, Inc. | 3.33B | 8.25% | 595,480 | 463.98M |
| 69 | CELC | Celcuity Inc. | 3.32B | -0.15% | 335,390 | - |
| 70 | TARS | Tarsus Pharmaceuticals, Inc. | 3.20B | 1.01% | 147,231 | 606.33M |
| 71 | DYN | Dyne Therapeutics, Inc. | 3.19B | 4.49% | 1,483,495 | - |
| 72 | RCUS | Arcus Biosciences, Inc. | 3.08B | 1.34% | 180,230 | 117.00M |
| 73 | DNLI | Denali Therapeutics Inc. | 3.06B | 2.41% | 335,949 | 3.60M |
| 74 | ELVN | Enliven Therapeutics, Inc. | 3.02B | 1.61% | 373,702 | - |
| 75 | ZLAB | Zai Lab Limited | 2.83B | 1.65% | 463,424 | 449.61M |
| 76 | PGEN | Precigen, Inc. | 2.77B | 1.84% | 1,606,440 | 85.72M |
| 77 | BEAM | Beam Therapeutics Inc. | 2.60B | 5.69% | 668,525 | 156.04M |
| 78 | NAMS | NewAmsterdam Pharma Company N.V. | 2.59B | 1.88% | 578,854 | 7.12M |
| 79 | MBX | MBX Biosciences, Inc. | 2.54B | -0.85% | 174,010 | - |
| 80 | IRON | Disc Medicine, Inc. | 2.41B | 3.44% | 125,191 | - |
| 81 | NRIX | Nurix Therapeutics, Inc. | 2.39B | 3.51% | 525,461 | 36.77M |
| 82 | CLDX | Celldex Therapeutics, Inc. | 2.36B | 2.70% | 316,465 | 158.00K |
| 83 | SLS | SELLAS Life Sciences Group, Inc. | 2.35B | 3.20% | 1,884,408 | - |
| 84 | HRMY | Harmony Biosciences Holdings, Inc. | 2.35B | 1.74% | 106,601 | 959.90M |
| 85 | RXRX | Recursion Pharmaceuticals, Inc. | 2.32B | 9.37% | 17,032,566 | 54.86M |
| 86 | ADMA | ADMA Biologics, Inc. | 2.31B | -0.05% | 778,385 | 512.28M |
| 87 | AUPH | Aurinia Pharmaceuticals Inc. | 2.24B | 3.79% | 316,021 | 311.51M |
| 88 | IMNM | Immunome, Inc. | 2.23B | 1.81% | 242,886 | 4.02M |
| 89 | PHVS | Pharvaris N.V. | 2.23B | 2.19% | 260,881 | - |
| 90 | VERA | Vera Therapeutics, Inc. | 2.15B | 0.25% | 203,508 | - |
| 91 | VRDN | Viridian Therapeutics, Inc. | 2.10B | 0.90% | 298,323 | 71.13M |
| 92 | VCEL | Vericel Corporation | 2.07B | 0.82% | 154,833 | 306.30M |
| 93 | NVAX | Novavax, Inc. | 2.04B | 12.44% | 9,432,158 | 413.80M |
| 94 | MLYS | Mineralys Therapeutics, Inc. | 2.03B | 2.84% | 337,708 | - |
| 95 | VIR | Vir Biotechnology, Inc. | 1.98B | 5.22% | 618,299 | 303.23M |
| 96 | ADRX | ADARx Pharmaceuticals, Inc. | 1.97B | -0.65% | 401,726 | 6.13M |
| 97 | PVLA | Palvella Therapeutics, Inc. | 1.96B | 3.55% | 49,563 | - |
| 98 | FTRE | Fortrea Holdings Inc. | 1.95B | 0.42% | 297,851 | 2.68B |
| 99 | SRPT | Sarepta Therapeutics, Inc. | 1.91B | -0.82% | 620,982 | 1.97B |
| 100 | AGIO | Agios Pharmaceuticals, Inc. | 1.90B | -0.33% | 229,386 | 98.34M |
| 101 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.90B | 1.32% | 531,583 | 208.78M |
| 102 | LKFT | Lakefront Biotherapeutics NV | 1.89B | 0.34% | 109,521 | 1.13B |
| 103 | MESO | Mesoblast Limited | 1.88B | 3.93% | 91,269 | 120.25M |
| 104 | XNCR | Xencor, Inc. | 1.86B | 2.29% | 239,376 | 104.97M |
| 105 | TRVI | Trevi Therapeutics, Inc. | 1.86B | 1.83% | 753,392 | - |
| 106 | GENB | Generate Biomedicines, Inc. | 1.86B | 3.36% | 329,250 | 26.48M |
| 107 | GPCR | Structure Therapeutics Inc. | 1.85B | 1.01% | 212,680 | - |
| 108 | ZYME | Zymeworks Inc. | 1.84B | 2.77% | 173,551 | 37.13M |
| 109 | BHVN | Biohaven Ltd. | 1.83B | 1.34% | 493,045 | - |
| 110 | URGN | UroGen Pharma Ltd. | 1.82B | 0.54% | 247,312 | 188.73M |
| 111 | NTLA | Intellia Therapeutics, Inc. | 1.80B | 2.06% | 3,753,480 | 59.51M |
| 112 | SEPN | Septerna, Inc. | 1.80B | 4.31% | 191,949 | 98.88M |
| 113 | ZBIO | Zenas BioPharma, Inc. | 1.78B | 3.89% | 121,007 | 1.00M |
| 114 | ABSI | Absci Corporation | 1.75B | 14.09% | 2,140,289 | 1.56M |
| 115 | NUVB | Nuvation Bio Inc. | 1.74B | 0.20% | 737,412 | 169.90M |
| 116 | OCUL | Ocular Therapeutix, Inc. | 1.67B | 1.33% | 1,015,031 | 52.06M |
| 117 | BRVE | Braveheart Bio, Inc. | 1.65B | 5.81% | 83,885 | - |
| 118 | STOK | Stoke Therapeutics, Inc. | 1.62B | 4.97% | 104,886 | 27.59M |
| 119 | COAG | Hemab Therapeutics Holdings, Inc. | 1.58B | 9.39% | 253,750 | - |
| 120 | QURE | uniQure N.V. | 1.57B | 0.35% | 307,219 | 18.67M |
| 121 | KRSA | Korsana Biosciences, Inc. | 1.55B | 1.48% | 16,324 | - |
| 122 | RARE | Ultragenyx Pharmaceutical Inc. | 1.53B | 1.70% | 955,090 | 717.00M |
| 123 | INVA | Innoviva, Inc. | 1.52B | 1.01% | 99,475 | 440.00M |
| 124 | SNDX | Syndax Pharmaceuticals, Inc. | 1.52B | 0.65% | 523,518 | 252.25M |
| 125 | IMCR | Immunocore Holdings plc | 1.52B | 1.34% | 63,796 | 430.78M |
| 126 | MAZE | Maze Therapeutics, Inc. | 1.48B | 3.09% | 200,922 | 20.00M |
| 127 | TSHA | Taysha Gene Therapies, Inc. | 1.47B | 1.81% | 1,563,331 | 5.49M |
| 128 | KLRA | Kailera Therapeutics, Inc. | 1.46B | 12.90% | 837,541 | - |
| 129 | RAPP | Rapport Therapeutics, Inc. | 1.46B | 2.01% | 71,213 | 20.00M |
| 130 | GHRS | GH Research PLC | 1.43B | 1.98% | 51,024 | - |
| 131 | OMER | Omeros Corporation | 1.43B | 2.98% | 307,026 | 38.42M |
| 132 | KARD | Kardigan, Inc. | 1.42B | 7.32% | 199,678 | - |
| 133 | NKTR | Nektar Therapeutics | 1.41B | 1.57% | 351,242 | 54.59M |
| 134 | TYRA | Tyra Biosciences, Inc. | 1.41B | 2.60% | 151,142 | - |
| 135 | ANAB | AnaptysBio, Inc. | 1.41B | 1.82% | 147,568 | 106.09M |
| 136 | INBX | Inhibrx Biosciences, Inc. | 1.39B | 2.10% | 36,811 | 1.30M |
| 137 | AAPG | Ascentage Pharma Group International | 1.33B | 0.86% | 732 | 94.61M |
| 138 | DRTS | Alpha Tau Medical Ltd. | 1.33B | 3.14% | 187,600 | - |
| 139 | DMRA | Damora Therapeutics, Inc. | 1.30B | 2.38% | 84,428 | - |
| 140 | ORIC | ORIC Pharmaceuticals, Inc. | 1.27B | 1.66% | 602,743 | - |
| 141 | NBTX | Nanobiotix S.A. | 1.26B | 4.02% | 28,886 | 13.15M |
| 142 | SVRA | Savara Inc. | 1.25B | 2.07% | 385,363 | - |
| 143 | REPL | Replimune Group, Inc. | 1.25B | 1.61% | 686,163 | - |
| 144 | LBRX | LB Pharmaceuticals Inc | 1.22B | 8.90% | 226,344 | - |
| 145 | VOR | Vor Biopharma Inc. | 1.19B | 4.81% | 589,976 | - |
| 146 | BCAX | Bicara Therapeutics Inc. | 1.17B | 2.14% | 241,816 | - |
| 147 | JANX | Janux Therapeutics, Inc. | 1.15B | 1.62% | 585,236 | 24.00M |
| 148 | AVLN | Avalyn Pharma Inc. | 1.14B | 0.35% | 89,133 | - |
| 149 | TRAX | First Tracks Biotherapeutics, Inc. | 1.13B | -1.06% | 515,867 | - |
| 150 | ANL | Adlai Nortye Group Ltd. | 1.06B | 6.38% | 136,600 | 18.06M |
| 151 | MNKD | MannKind Corporation | 1.04B | -5.26% | 1,520,606 | 393.63M |
| 152 | MGTX | MeiraGTx Holdings plc | 1.03B | 2.57% | 122,403 | 397.50M |
| 153 | LTGO | Latigo Biotherapeutics, Inc. | 1.03B | 5.24% | 44,695 | - |
| 154 | CGEM | Cullinan Therapeutics, Inc. | 1.02B | 2.13% | 167,536 | - |
| 155 | IMTX | Immatics N.V. | 995.10M | -1.22% | 645,227 | 47.65M |
| 156 | AKTS | Aktis Oncology, Inc. | 991.70M | 0.51% | 107,171 | 10.06M |
| 157 | SPTX | Seaport Therapeutics, Inc. | 984.43M | 2.68% | 28,997 | - |
| 158 | ANRO | Alto Neuroscience, Inc. | 981.84M | 4.12% | 149,711 | - |
| 159 | KURA | Kura Oncology, Inc. | 927.86M | -0.86% | 446,715 | 77.23M |
| 160 | JBIO | Jade Biosciences, Inc. | 927.25M | 3.04% | 291,662 | - |
| 161 | MLTX | MoonLake Immunotherapeutics | 922.56M | 2.46% | 860,847 | - |
| 162 | RIGL | Rigel Pharmaceuticals, Inc. | 916.81M | 0.74% | 84,203 | 276.79M |
| 163 | ALMS | Alumis Inc. | 913.81M | 1.29% | 411,326 | 7.40M |
| 164 | ODTX | Odyssey Therapeutics, Inc. | 909.25M | 4.72% | 103,151 | 99.00K |
| 165 | GLUE | Monte Rosa Therapeutics, Inc. | 886.41M | 0.68% | 371,234 | 28.73M |
| 166 | DNA | Ginkgo Bioworks Holdings, Inc. | 872.73M | 14.29% | 2,299,976 | 132.42M |
| 167 | SLBT | SL Science Holding Limited | 872.51M | 0.66% | 13,687 | 3.27M |
| 168 | CRVS | Corvus Pharmaceuticals, Inc. | 864.76M | 0.69% | 219,931 | - |
| 169 | AVBP | ArriVent BioPharma, Inc. | 853.02M | 3.53% | 706,956 | - |
| 170 | SGP | SpyGlass Pharma, Inc. | 850.25M | 3.25% | 8,915 | - |
| 171 | SANA | Sana Biotechnology, Inc. | 850.18M | 1.79% | 1,341,346 | - |
| 172 | HELP | Helus Pharma Inc. | 832.16M | 6.25% | 637,446 | - |
| 173 | ABUS | Arbutus Biopharma Corporation | 830.96M | 0.48% | 877,323 | 181.72M |
| 174 | OBX | Obsidian Therapeutics, Inc. | 821.58M | 8.66% | 194,957 | - |
| 175 | ARDX | Ardelyx, Inc. | 809.86M | -0.61% | 835,957 | 450.89M |
| 176 | GERN | Geron Corporation | 796.67M | 1.64% | 1,767,894 | 204.56M |
| 177 | APMD | Apnimed, Inc. | 782.03M | 3.10% | 90,719 | 115.12M |
| 178 | IMMX | Immix Biopharma, Inc. | 778.46M | 1.08% | 455,129 | - |
| 179 | ANNX | Annexon, Inc. | 775.38M | 2.25% | 423,971 | - |
| 180 | LXRX | Lexicon Pharmaceuticals, Inc. | 769.77M | -1.70% | 639,906 | 41.47M |
| 181 | ACHV | Achieve Life Sciences, Inc. | 755.30M | 2.09% | 274,719 | - |
| 182 | ATTO | Attovia Therapeutics, Inc. | 754.62M | 1.35% | 34,771 | 1.80M |
| 183 | GYRE | Gyre Therapeutics, Inc. | 750.72M | 4.73% | 25,429 | 109.82M |
| 184 | CADL | Candel Therapeutics, Inc. | 749.88M | 1.45% | 231,211 | - |
| 185 | FDMT | 4D Molecular Therapeutics, Inc. | 745.52M | 6.26% | 286,669 | 92.01M |
| 186 | SLDB | Solid Biosciences Inc. | 744.14M | 1.76% | 230,075 | - |
| 187 | VSTM | Verastem, Inc. | 739.90M | 0.74% | 1,048,705 | 87.53M |
| 188 | AVTX | Avalo Therapeutics, Inc. | 736.34M | 2.23% | 203,343 | 59.00K |
| 189 | DSGN | Design Therapeutics, Inc. | 733.14M | 1.96% | 102,020 | - |
| 190 | PRME | Prime Medicine, Inc. | 724.96M | 13.83% | 4,289,271 | 4.07M |
| 191 | IVA | Inventiva S.A. | 708.50M | -4.37% | 772,784 | 2.81M |
| 192 | OABI | OmniAb, Inc. | 700.05M | 3.33% | 408,503 | 38.46M |
| 193 | OLMA | Olema Pharmaceuticals, Inc. | 699.11M | 2.17% | 196,067 | - |
| 194 | AURA | Aura Biosciences, Inc. | 691.71M | 2.54% | 182,430 | - |
| 195 | WVE | Wave Life Sciences, Inc. | 687.70M | 0.58% | 571,582 | 65.37M |
| 196 | MDXG | MiMedx Group, Inc. | 679.24M | 0.87% | 86,080 | 355.17M |
| 197 | ZVRA | Zevra Therapeutics, Inc. | 676.38M | 3.55% | 209,472 | 136.07M |
| 198 | PHAR | Pharming Group N.V. | 669.37M | -0.05% | 2,248 | 366.48M |
| 199 | NVCT | Nuvectis Pharma, Inc. | 667.92M | 1.84% | 19,295 | - |
| 200 | FTH | Faeth Therapeutics, Inc. | 656.61M | -0.78% | 65,208 | - |
| 201 | CLYM | Climb Bio, Inc. | 636.97M | 2.12% | 208,227 | - |
| 202 | CBIO | Crescent Biopharma, Inc. | 633.46M | 4.82% | 47,543 | 11.88M |
| 203 | SGMT | Sagimet Biosciences Inc. | 630.38M | -0.34% | 230,047 | - |
| 204 | SLN | Silence Therapeutics plc | 620.76M | 8.30% | 331,825 | 615.00K |
| 205 | CRMD | CorMedix Inc. | 577.18M | 1.16% | 300,360 | 462.25M |
| 206 | ACRS | Aclaris Therapeutics, Inc. | 573.34M | 2.77% | 1,203,413 | 8.22M |
| 207 | ETRA | Electra Therapeutics, Inc. | 572.43M | -0.22% | 57,224 | - |
| 208 | PHAT | Phathom Pharmaceuticals, Inc. | 569.12M | 0.49% | 179,547 | 239.66M |
| 209 | STTK | Shattuck Labs, Inc. | 567.05M | -0.18% | 186,405 | 1.00M |
| 210 | DBVT | DBV Technologies S.A. | 552.65M | -1.26% | 115,201 | 5.04M |
| 211 | MNPR | Monopar Therapeutics Inc. | 551.81M | -2.11% | 47,560 | - |
| 212 | CTMX | CytomX Therapeutics, Inc. | 544.75M | 1.21% | 1,064,069 | 18.30M |
| 213 | BLSM | BlossomHill Therapeutics, Inc. | 543.52M | 1.30% | 34,049 | - |
| 214 | NGNE | Neurogene Inc. | 540.11M | 1.85% | 194,541 | 925.00K |
| 215 | RGNX | REGENXBIO Inc. | 536.69M | 0.49% | 279,071 | 174.48M |
| 216 | DRUG | Bright Minds Biosciences Inc. | 536.49M | 5.35% | 50,046 | - |
| 217 | VALN | Valneva SE | 534.23M | 1.23% | 1,734 | 163.30M |
| 218 | OCS | Oculis Holding AG | 531.51M | -0.58% | 45,628 | 1.45M |
| 219 | PBYI | Puma Biotechnology, Inc. | 525.49M | 2.11% | 88,476 | 231.24M |
| 220 | RZLT | Rezolute, Inc. | 513.99M | 5.60% | 792,203 | - |
| 221 | PROK | ProKidney Corp. | 513.95M | 2.41% | 267,593 | 818.00K |
| 222 | ALT | Altimmune, Inc. | 506.50M | 0.15% | 772,231 | 31.00K |
| 223 | CTNM | Contineum Therapeutics, Inc. | 504.69M | 1.78% | 196,642 | - |
| 224 | ARVN | Arvinas, Inc. | 501.19M | 2.06% | 168,629 | 316.70M |
| 225 | ALLO | Allogene Therapeutics, Inc. | 495.78M | 2.50% | 5,489,484 | 4.64M |
| 226 | MPLT | MapLight Therapeutics, Inc. | 492.96M | -3.06% | 150,868 | - |
| 227 | EPRX | Eupraxia Pharmaceuticals Inc. | 486.76M | -1.98% | 514,358 | - |
| 228 | AUTL | Autolus Therapeutics plc | 476.43M | 1.13% | 581,419 | 117.39M |
| 229 | ASMB | Assembly Biosciences, Inc. | 475.32M | 2.30% | 29,767 | 74.85M |
| 230 | OVID | Ovid Therapeutics Inc. | 474.57M | 3.85% | 523,914 | 1.58M |
| 231 | YDES | YD Bio Limited | 474.57M | 15.72% | 160,892 | 1.24M |
| 232 | PRTA | Prothena Corporation plc | 473.33M | 7.08% | 292,899 | 54.53M |
| 233 | ENTX | Entera Bio Ltd. | 460.56M | 6.40% | 451,735 | 42.00K |
| 234 | AGMB | AgomAb Therapeutics NV | 456.53M | 0.54% | 52,281 | - |
| 235 | CAPR | Capricor Therapeutics, Inc. | 454.07M | -2.50% | 897,741 | 11.13M |
| 236 | TECX | Tectonic Therapeutic, Inc. | 452.96M | 1.85% | 30,786 | - |
| 237 | EDIT | Editas Medicine, Inc. | 443.85M | 1.76% | 1,035,820 | 47.01M |
| 238 | DMAC | DiaMedica Therapeutics Inc. | 440.03M | 1.87% | 35,538 | - |
| 239 | SPRY | ARS Pharmaceuticals, Inc. | 426.63M | -5.92% | 419,865 | 116.93M |
| 240 | AVIR | Atea Pharmaceuticals, Inc. | 412.25M | -0.29% | 37,474 | - |
| 241 | EIKN | Eikon Therapeutics, Inc. | 408.68M | 0.60% | 97,789 | - |
| 242 | PRLD | Prelude Therapeutics Incorporated | 406.83M | 1.80% | 75,212 | 22.42M |
| 243 | ZURA | Zura Bio Limited | 398.65M | 0.73% | 423,763 | - |
| 244 | KYTX | Kyverna Therapeutics, Inc. | 398.27M | 4.21% | 330,178 | - |
| 245 | ARCT | Arcturus Therapeutics Holdings Inc. | 388.26M | 6.14% | 306,244 | 29.37M |
| 246 | IRD | Opus Genetics, Inc. | 385.20M | 3.81% | 482,813 | 9.86M |
| 247 | CCCC | C4 Therapeutics, Inc. | 380.15M | 8.42% | 1,227,341 | 35.04M |
| 248 | GALT | Galectin Therapeutics Inc. | 378.19M | 3.02% | 35,660 | - |
| 249 | VTVT | vTv Therapeutics Inc. | 377.28M | 0.95% | 7,309 | 36.84M |
| 250 | FENC | Fennec Pharmaceuticals Inc. | 374.52M | 0.47% | 33,348 | 59.22M |
| 251 | RLMD | Relmada Therapeutics, Inc. | 372.28M | 10.09% | 734,971 | - |
| 252 | SCTX | Scribe Therapeutics Inc. | 371.44M | 2.03% | 182,374 | 33.30M |
| 253 | TRXB | TRex Bio, Inc. | 370.18M | -1.79% | 495,892 | - |
| 254 | ENTA | Enanta Pharmaceuticals, Inc. | 357.37M | 1.40% | 57,636 | 65.26M |
| 255 | SRZN | Surrozen, Inc. | 351.43M | 6.90% | 396,532 | 11.51M |
| 256 | IKT | Inhibikase Therapeutics, Inc. | 345.94M | -0.52% | 122,236 | 1.00 |
| 257 | OBIO | Orchestra BioMed Holdings, Inc. | 345.60M | 0.35% | 74,308 | 31.98M |
| 258 | ARTV | Artiva Biotherapeutics, Inc. | 344.19M | 3.53% | 87,048 | 251.00K |
| 259 | TTRX | Turn Therapeutics Inc. | 343.16M | 1.14% | 27,878 | - |
| 260 | AGEN | Agenus Inc. | 340.35M | 0.27% | 330,523 | 132.69M |
| 261 | INDP | Indaptus Therapeutics, Inc. | 338.44M | 7.17% | 330,347 | - |
| 262 | CABA | Cabaletta Bio, Inc. | 328.07M | -0.77% | 889,713 | - |
| 263 | OCGN | Ocugen, Inc. | 321.41M | -3.03% | 5,212,224 | 4.58M |
| 264 | BNTC | Benitec Biopharma Inc. | 310.28M | 1.66% | 19,723 | - |
| 265 | EYPT | EyePoint, Inc. | 299.16M | 0.29% | 620,465 | 2.79M |
| 266 | NAUT | Nautilus Biotechnology, Inc. | 292.05M | 26.10% | 6,424,292 | 190.00K |
| 267 | ABEO | Abeona Therapeutics Inc. | 287.06M | 1.21% | 384,027 | 25.52M |
| 268 | RCKT | Rocket Pharmaceuticals, Inc. | 287.06M | -0.57% | 1,881,863 | - |
| 269 | XFOR | X4 Pharmaceuticals, Inc. | 286.53M | 3.58% | 143,381 | 15.85M |
| 270 | FULC | Fulcrum Therapeutics, Inc. | 285.73M | -0.13% | 616,955 | 80.00M |
| 271 | VOGX | Vogenx, Inc. | 280.46M | 7.95% | 23,946 | - |
| 272 | CUVL | Clinuvel Pharmaceuticals Limited | 277.47M | -0.36% | 70 | 65.05M |
| 273 | LRMR | Larimar Therapeutics, Inc. | 277.14M | -1.67% | 327,695 | - |
| 274 | VNDA | Vanda Pharmaceuticals Inc. | 274.20M | 0.11% | 210,368 | 215.72M |
| 275 | IPSC | Century Therapeutics, Inc. | 273.42M | 3.42% | 344,325 | 109.16M |
| 276 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 272.99M | -0.44% | 230,198 | - |
| 277 | PALI | Palisade Bio, Inc. | 271.86M | 7.59% | 750,422 | 500.00K |
| 278 | BCYC | Bicycle Therapeutics plc | 268.77M | 0.79% | 131,538 | 61.21M |
| 279 | SABS | SAB Biotherapeutics, Inc. | 267.50M | 1.73% | 222,572 | 114.70K |
| 280 | FATE | Fate Therapeutics, Inc. | 264.20M | 3.52% | 366,075 | 6.49M |
| 281 | LXEO | Lexeo Therapeutics, Inc. | 261.31M | -0.78% | 337,022 | - |
| 282 | LCTX | Lineage Cell Therapeutics, Inc. | 254.17M | -2.43% | 614,609 | 13.08M |
| 283 | ACIU | AC Immune SA | 253.04M | -0.20% | 44,057 | 21.67M |
| 284 | VCRE | Vicore Pharma Holding AB (publ) | 251.27M | 2.61% | 20,085 | 412.09K |
| 285 | UPB | Upstream Bio, Inc. | 250.30M | 0.44% | 306,401 | 3.16M |
| 286 | ZNTL | Zentalis Pharmaceuticals, Inc. | 249.93M | 5.18% | 308,917 | 26.87M |
| 287 | IMRX | Immuneering Corporation | 246.50M | 1.87% | 363,636 | - |
| 288 | IFRX | InflaRx N.V. | 246.10M | 9.15% | 372,866 | -11.54K |
| 289 | STRO | Sutro Biopharma, Inc. | 245.57M | -3.33% | 55,378 | 45.70M |
| 290 | PYXS | Pyxis Oncology, Inc. | 243.69M | 2.51% | 319,017 | 11.04M |
| 291 | QTTB | Q32 Bio Inc. | 240.83M | - | 316,862 | 53.74M |
| 292 | KROS | Keros Therapeutics, Inc. | 236.93M | 2.66% | 50,437 | 15.01M |
| 293 | GLSI | Greenwich LifeSciences, Inc. | 234.85M | 5.68% | 62,748 | - |
| 294 | MGNX | MacroGenics, Inc. | 234.10M | 3.52% | 105,878 | 175.14M |
| 295 | CAMP | Camp4 Therapeutics Corporation | 233.44M | 0.54% | 15,994 | 4.22M |
| 296 | ALEC | Alector, Inc. | 232.80M | 3.22% | 870,945 | 13.86M |
| 297 | SLGL | Sol-Gel Technologies Ltd. | 227.42M | -1.25% | 6,399 | 1.80M |
| 298 | EVMN | Evommune, Inc. | 225.01M | -3.28% | 273,486 | 10.00M |
| 299 | PRQR | ProQR Therapeutics N.V. | 223.68M | 0.96% | 326,402 | 21.05M |
| 300 | SION | Sionna Therapeutics, Inc. | 221.99M | 0.20% | 158,084 | - |
| 301 | PLX | Protalix BioTherapeutics, Inc. | 221.17M | 1.67% | 517,214 | 80.62M |
| 302 | LYEL | Lyell Immunopharma, Inc. | 218.10M | 1.25% | 29,929 | 27.00K |
| 303 | IVVD | Invivyd, Inc. | 214.88M | 4.08% | 1,102,171 | 58.37M |
| 304 | RNAC | Cartesian Therapeutics, Inc. | 209.67M | 1.61% | 60,315 | 1.48M |
| 305 | TRDA | Entrada Therapeutics, Inc. | 203.18M | 1.90% | 50,591 | 4.69M |
| 306 | CGEN | Compugen Ltd. | 200.82M | - | 48,646 | 74.00M |
| 307 | ELDN | Eledon Pharmaceuticals, Inc. | 199.69M | 1.45% | 208,842 | - |
| 308 | ACOG | Alpha Cognition Inc. | 199.49M | 1.33% | 4,290 | 15.26M |
| 309 | WHWK | Whitehawk Therapeutics, Inc. | 196.68M | -0.58% | 86,655 | 7.15M |
| 310 | CUE | Cue Biopharma, Inc. | 192.22M | 18.50% | 130,495 | 37.66M |
| 311 | YARW | Yarrow Bioscience, Inc. | 190.46M | 3.02% | 81,607 | - |
| 312 | DTIL | Precision BioSciences, Inc. | 188.79M | 6.38% | 123,530 | 45.06M |
| 313 | CMPX | Compass Therapeutics, Inc. | 188.19M | 6.26% | 656,195 | 850.00K |
| 314 | NGEN | NervGen Pharma Corp. | 186.01M | -1.14% | 148,017 | - |
| 315 | PEPG | PepGen Inc. | 181.81M | 10.29% | 268,890 | - |
| 316 | ADAG | Adagene Inc. | 179.27M | -3.96% | 633,077 | 9.29M |
| 317 | ORMP | Oramed Pharmaceuticals Inc. | 176.79M | 1.19% | 90,312 | 2.00M |
| 318 | VRXA | Veraxa Biotech AG | 176.76M | 14.68% | 1,465,447 | 29.54K |
| 319 | CNTN | Canton Strategic Holdings, Inc. | 173.71M | 4.81% | 285,371 | 1.50M |
| 320 | ALXO | ALX Oncology Holdings Inc. | 171.46M | 5.08% | 380,069 | - |
| 321 | ANTX | AN2 Therapeutics, Inc. | 170.19M | -3.63% | 248,132 | - |
| 322 | CHRS | Coherus Oncology, Inc. | 167.63M | 1.40% | 688,197 | 50.94M |
| 323 | MDWD | MediWound Ltd. | 162.75M | 1.50% | 34,508 | 11.86M |
| 324 | NBP | NovaBridge Biosciences | 162.40M | 2.19% | 153,537 | - |
| 325 | TARA | Protara Therapeutics, Inc. | 161.04M | 2.83% | 440,158 | - |
| 326 | MSLE | Satellos Bioscience Inc. | 160.64M | 3.47% | 24,850 | - |
| 327 | MENS | Jyong Biotech Ltd. | 155.15M | -0.48% | 25,656 | - |
| 328 | KRRO | Korro Bio, Inc. | 154.77M | -0.66% | 40,294 | 2.38M |
| 329 | ABOS | Acumen Pharmaceuticals, Inc. | 154.04M | 1.43% | 133,790 | - |
| 330 | NKTX | Nkarta, Inc. | 153.99M | -3.15% | 203,397 | - |
| 331 | TLSA | Tiziana Life Sciences Ltd | 153.94M | 5.35% | 1,042,880 | - |
| 332 | NERV | Minerva Neurosciences, Inc. | 151.84M | -1.24% | 8,303 | - |
| 333 | CDXS | Codexis, Inc. | 151.67M | 1.84% | 238,177 | 77.68M |
| 334 | VYGR | Voyager Therapeutics, Inc. | 150.04M | 2.74% | 235,288 | 34.46M |
| 335 | MOLN | Molecular Partners AG | 149.40M | -1.84% | 509 | 856.30K |
| 336 | RNA | Atrium Therapeutics, Inc. | 143.52M | 1.57% | 44,832 | 35.84M |
| 337 | ARMP | Armata Pharmaceuticals, Inc. | 142.04M | -1.04% | 20,612 | 5.54M |
| 338 | OTLK | Outlook Therapeutics, Inc. | 138.91M | 1.17% | 1,211,541 | -1.16M |
| 339 | IPHA | Innate Pharma S.A. | 138.22M | 4.05% | 29,773 | 11.21M |
| 340 | AVXL | Anavex Life Sciences Corp. | 133.95M | -6.17% | 522,233 | - |
| 341 | HURA | TuHURA Biosciences, Inc. | 125.22M | 1.81% | 58,694 | - |
| 342 | SPRB | Spruce Biosciences, Inc. | 125.11M | -4.41% | 33,352 | 697.00K |
| 343 | TNXP | Tonix Pharmaceuticals Holding Corp. | 124.17M | -0.55% | 584,556 | 29.10M |
| 344 | NRXP | NRx Pharmaceuticals, Inc. | 124.16M | -0.69% | 112,696 | 3.39M |
| 345 | TNYA | Tenaya Therapeutics, Inc. | 123.97M | 1.59% | 1,693,935 | 1.34M |
| 346 | SEER | Seer, Inc. | 122.93M | 2.30% | 125,945 | 14.22M |
| 347 | KZIA | Kazia Therapeutics Limited | 122.92M | 1.70% | 29,918 | 1.27M |
| 348 | FHTX | Foghorn Therapeutics Inc. | 121.74M | 3.02% | 318,491 | 36.74M |
| 349 | PMVP | PMV Pharmaceuticals, Inc. | 119.69M | 6.38% | 219,006 | - |
| 350 | ENGN | enGene Therapeutics Inc. | 118.62M | -0.56% | 122,041 | - |
| 351 | CBUS | Cibus, Inc. | 117.70M | -3.14% | 17,839 | 4.35M |
| 352 | COYA | Coya Therapeutics, Inc. | 117.29M | 0.20% | 41,414 | 8.02M |
| 353 | IMUX | Immunic, Inc. | 116.80M | 13.23% | 233,719 | - |
| 354 | UNCY | Unicycive Therapeutics, Inc. | 115.18M | 1.60% | 228,833 | - |
| 355 | CNXU | Conexeu Sciences Inc. | 113.67M | 16.81% | 237,972 | - |
| 356 | INO | Inovio Pharmaceuticals, Inc. | 113.22M | 0.46% | 1,111,260 | 65.34K |
| 357 | LENZ | LENZ Therapeutics, Inc. | 113.11M | 1.98% | 269,214 | 21.48M |
| 358 | RANI | Rani Therapeutics Holdings, Inc. | 112.03M | 1.48% | 107,063 | 4.88M |
| 359 | HUMA | Humacyte, Inc. | 111.65M | -10.11% | 3,739,314 | 2.12M |
| 360 | VANI | Vivani Medical, Inc. | 111.40M | 0.41% | 69,520 | - |
| 361 | GNLX | Genelux Corporation | 111.13M | -0.80% | 34,713 | 8.00K |
| 362 | TVGN | Tevogen Inc. | 109.53M | -1.42% | 1,619 | - |
| 363 | MIST | Milestone Pharmaceuticals Inc. | 106.19M | 5.83% | 560,334 | 2.34M |
| 364 | TENX | Tenax Therapeutics, Inc. | 105.40M | -1.08% | 861,303 | - |
| 365 | BDTX | Black Diamond Therapeutics, Inc. | 104.28M | 0.28% | 166,665 | 70.00M |
| 366 | PYPD | PolyPid Ltd. | 103.37M | 3.86% | 19,987 | - |
| 367 | BMEA | Biomea Fusion, Inc. | 102.93M | 3.65% | 607,350 | - |
| 368 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 102.90M | 0.95% | 207,784 | - |
| 369 | AARD | Aardvark Therapeutics, Inc. | 102.20M | -0.85% | 69,056 | - |
| 370 | ANIX | Anixa Biosciences, Inc. | 101.93M | 0.76% | 64,899 | - |
| 371 | PLYX | Polaryx Therapeutics, Inc. | 101.19M | 1.50% | 4,987 | - |
| 372 | ATRA | Atara Biotherapeutics, Inc. | 96.16M | 3.79% | 3,342 | 6.19M |
| 373 | OKUR | OnKure Therapeutics, Inc. | 94.76M | 1.74% | 269,980 | - |
| 374 | CLLS | Cellectis S.A. | 91.67M | - | 38,876 | 63.82M |
| 375 | NMRA | Neumora Therapeutics, Inc. | 91.20M | 1.17% | 243,276 | - |
| 376 | RLYB | Rallybio Corporation | 90.54M | 0.35% | 534 | 646.00K |
| 377 | PDSB | PDS Biotechnology Corporation | 89.87M | 21.57% | 5,201,205 | - |
| 378 | EQ | Equillium, Inc. | 89.72M | -1.74% | 188,907 | 4.39M |
| 379 | PMN | ProMIS Neurosciences, Inc. | 89.41M | 8.96% | 16,471 | - |
| 380 | RTSN | Retension Pharmaceuticals, Inc. | 89.15M | -10.83% | 242,447 | - |
| 381 | ICCC | ImmuCell Corporation | 88.46M | -0.10% | 680 | 30.68M |
| 382 | NRXS | NeurAxis, Inc. | 86.27M | 1.48% | 7,771 | 5.32M |
| 383 | CRDF | Cardiff Oncology, Inc. | 85.19M | 3.30% | 80,785 | 508.00K |
| 384 | CGTX | Cognition Therapeutics, Inc. | 84.77M | -0.42% | 188,142 | - |
| 385 | TELO | Telomir Pharmaceuticals, Inc. | 83.56M | -1.30% | 22,420 | - |
| 386 | NTRB | Nutriband Inc. | 82.54M | 12.23% | 31,100 | 1.62M |
| 387 | ACRV | Acrivon Therapeutics, Inc. | 82.28M | 2.67% | 51,767 | - |
| 388 | PTHS | Pelthos Therapeutics Inc. | 78.71M | 0.29% | 39,054 | 43.30M |
| 389 | MNOV | MediciNova, Inc. | 76.79M | 1.30% | 42,528 | 920.48K |
| 390 | HRTX | Heron Therapeutics, Inc. | 75.54M | 11.08% | 2,046,749 | 151.18M |
| 391 | OSTX | OS Therapies Incorporated | 73.80M | -1.23% | 120,177 | - |
| 392 | MAIA | MAIA Biotechnology, Inc. | 73.30M | 4.78% | 170,592 | - |
| 393 | OKYO | OKYO Pharma Limited | 72.95M | - | 2,669 | - |
| 394 | CING | Cingulate Inc. | 71.84M | 1.23% | 17,679 | - |
| 395 | VRCA | Verrica Pharmaceuticals Inc. | 71.46M | -0.48% | 25,269 | 30.32M |
| 396 | GANX | Gain Therapeutics, Inc. | 70.70M | 0.31% | 181,342 | - |
| 397 | FBIO | Fortress Biotech, Inc. | 70.54M | 1.20% | 56,657 | 68.47M |
| 398 | HYFT | MindWalk Holdings Corp. | 70.20M | 4.20% | 150,833 | 11.57M |
| 399 | CSBR | Champions Oncology, Inc. | 69.45M | 0.20% | 39 | 60.66M |
| 400 | ONCY | Oncolytics Biotech Inc. | 68.86M | -0.81% | 630,910 | - |
| 401 | SPRO | Spero Therapeutics, Inc. | 68.13M | 2.63% | 238,953 | 47.00M |
| 402 | NTHI | NeOnc Technologies Holdings, Inc. | 67.61M | 7.51% | 73,561 | 39.99K |
| 403 | RNTX | Rein Therapeutics Inc. | 67.16M | 1.20% | 202,367 | - |
| 404 | XBIT | XBiotech Inc. | 67.12M | 0.06% | 26,787 | - |
| 405 | PLRX | Pliant Therapeutics, Inc. | 63.16M | 2.00% | 141,626 | - |
| 406 | ACET | Adicet Bio, Inc. | 61.52M | -0.44% | 68,673 | - |
| 407 | ELOX | Eloxx Pharmaceuticals, Inc. | 60.12M | -1.88% | 4,698 | - |
| 408 | ALPS | Alps Group Inc | 59.90M | -2.52% | 2,930 | 3.74M |
| 409 | XLO | Xilio Therapeutics, Inc. | 59.75M | 0.78% | 1,869 | 64.09M |
| 410 | GUTS | Fractyl Health, Inc. | 59.23M | 5.56% | 86,693 | 3.00K |
| 411 | GOSS | Gossamer Bio, Inc. | 58.78M | -2.73% | 95,328 | 53.29M |
| 412 | RNXT | RenovoRx, Inc. | 58.67M | -2.26% | 246,147 | 1.98M |
| 413 | KLRS | Kalaris Therapeutics, Inc. | 58.56M | -1.60% | 838 | - |
| 414 | ALDX | Aldeyra Therapeutics, Inc. | 57.76M | 1.03% | 137,880 | - |
| 415 | ATHE | Alterity Therapeutics Limited | 57.68M | 1.63% | 5,195 | 2.50M |
| 416 | MREO | Mereo BioPharma Group plc | 57.58M | -3.89% | 373,433 | 500.00K |
| 417 | CNTB | Connect Biopharma Holdings Limited | 57.36M | 3.43% | 264,699 | 2.95M |
| 418 | BOLD | Boundless Bio, Inc. | 57.32M | -2.33% | 44,430 | - |
| 419 | IBIO | iBio, Inc. | 56.59M | -4.35% | 508,979 | 100.00K |
| 420 | CLNN | Clene Inc. | 55.22M | 0.13% | 32,121 | 197.00K |
| 421 | INKT | MiNK Therapeutics, Inc. | 54.60M | -2.73% | 13,343 | - |
| 422 | LONA | LeonaBio, Inc. | 54.55M | 0.70% | 8,045 | - |
| 423 | CRBU | Caribou Biosciences, Inc. | 53.60M | 3.91% | 3,913,843 | 10.04M |
| 424 | HYPD | Hyperion DeFi, Inc. | 53.46M | 2.23% | 85,353 | 1.40M |
| 425 | INMB | INmune Bio Inc. | 51.48M | 1.37% | 21,126 | 50.00K |
| 426 | SER | Serina Therapeutics, Inc. | 51.44M | 0.75% | 20,614 | 130.00K |
| 427 | CELU | Celularity Inc. | 50.29M | 6.16% | 25,838 | 18.97M |
| 428 | DWTX | Dogwood Therapeutics, Inc. | 49.97M | 4.26% | 37,412 | - |
| 429 | CRVO | CervoMed Inc. | 49.67M | 0.15% | 90,091 | 331.30K |
| 430 | ANVS | Annovis Bio, Inc. | 49.64M | -0.43% | 164,946 | - |
| 431 | APLM | Apollomics, Inc. | 49.41M | 3.31% | 4,510 | 8.84M |
| 432 | EXOZ | eXoZymes, Inc. | 48.91M | - | 258 | -700.00 |
| 433 | IMA | ImageneBio, Inc. | 48.13M | -0.47% | 5,605 | 800.00K |
| 434 | ELTX | Elicio Therapeutics, Inc. | 47.96M | 0.83% | 65,422 | - |
| 435 | EDSA | Edesa Biotech, Inc. | 47.70M | -3.55% | 21,110 | - |
| 436 | BSEM | BioStem Technologies, Inc. | 47.58M | -3.03% | 27,581 | 34.59M |
| 437 | HOWL | Werewolf Therapeutics, Inc. | 47.42M | 7.22% | 384,297 | 21.00M |
| 438 | TIL | Instil Bio, Inc. | 45.44M | 2.13% | 17,558 | - |
| 439 | GRCE | Grace Therapeutics, Inc. | 42.91M | - | 7,293 | - |
| 440 | VERU | Veru Inc. | 41.94M | 1.65% | 81,324 | 16.89M |
| 441 | FLNA | Filana Therapeutics, Inc. | 40.17M | 2.20% | 172,479 | - |
| 442 | MGX | Metagenomi Therapeutics, Inc. | 38.53M | 2.70% | 96,970 | 13.56M |
| 443 | LITS | Lite Strategy, Inc. | 38.31M | 3.28% | 220,184 | - |
| 444 | IBO | Impact BioMedical Inc. | 36.74M | 4.62% | 1,705 | 35.00K |
| 445 | BCTX | BriaCell Therapeutics Corp. | 34.49M | 1.53% | 13,532 | - |
| 446 | NNVC | NanoViricides, Inc. | 34.33M | 2.67% | 63,454 | - |
| 447 | QNCX | Quince Therapeutics, Inc. | 34.03M | 13.96% | 38,360 | - |
| 448 | ATNM | Actinium Pharmaceuticals, Inc. | 33.96M | - | 39,058 | 35.09M |
| 449 | CVM | CEL-SCI Corporation | 33.77M | -1.54% | 189,264 | - |
| 450 | GRDX | GridAI Technologies Corp. | 33.42M | -1.67% | 45,232 | - |
| 451 | ALGS | Aligos Therapeutics, Inc. | 33.22M | 0.19% | 2,608 | 31.52M |
| 452 | NXTC | NextCure, Inc. | 30.71M | -1.03% | 31,397 | - |
| 453 | RNAZ | TransCode Therapeutics, Inc. | 30.14M | 4.09% | 35,345 | - |
| 454 | IGC | IGC Pharma, Inc. | 28.92M | -1.83% | 179,305 | 1.11M |
| 455 | CNTX | Context Therapeutics Inc. | 28.02M | 2.01% | 234,798 | - |
| 456 | MCRB | Seres Therapeutics, Inc. | 27.20M | 2.97% | 34,745 | 1.88M |
| 457 | ABVC | ABVC BioPharma, Inc. | 26.18M | 3.06% | 20,050 | 797.92K |
| 458 | EVAX | Evaxion A/S | 25.85M | 1.64% | 23,921 | 7.49M |
| 459 | IMMP | Immutep Limited | 25.09M | -5.86% | 15,139 | 13.79M |
| 460 | KYNB | Kyntra Bio, Inc. | 24.86M | 3.02% | 3,715 | 4.62M |
| 461 | BYSI | BeyondSpring Inc. | 24.86M | -0.72% | 40,873 | 1.88M |
| 462 | QNTM | Quantum BioPharma Ltd. | 24.67M | -1.93% | 48,699 | - |
| 463 | ATYR | aTyr Pharma, Inc. | 24.52M | -2.08% | 470,050 | 190.00K |
| 464 | PLRZ | Polyrizon Ltd. | 23.07M | 7.10% | 9,944 | - |
| 465 | ATOS | Atossa Therapeutics, Inc. | 22.25M | -7.85% | 128,026 | - |
| 466 | QNRX | Quoin Pharmaceuticals, Ltd. | 21.62M | -1.10% | 20,495 | - |
| 467 | COCP | Cocrystal Pharma, Inc. | 20.52M | -0.47% | 2,319 | 330.00K |
| 468 | AKTX | Akari Therapeutics, Plc | 19.22M | 3.44% | 21,150 | - |
| 469 | PBM | Psyence Biomedical Ltd. | 19.07M | -2.34% | 12,864 | - |
| 470 | JSPR | Jasper Therapeutics, Inc. | 18.98M | 1.87% | 151,422 | - |
| 471 | NEUP | Neuphoria Therapeutics Inc. | 18.13M | - | 1,622 | 1.17M |
| 472 | NCEL | NewcelX Ltd. | 17.85M | -0.64% | 907 | - |
| 473 | ESLA | Estrella Immunopharma, Inc. | 16.70M | -8.02% | 18,743,898 | - |
| 474 | DYAI | Dyadic International, Inc. | 16.67M | 2.94% | 4,973 | 3.80M |
| 475 | MRKR | Marker Therapeutics, Inc. | 16.45M | 3.86% | 57,164 | 3.55M |
| 476 | ALLR | Allarity Therapeutics, Inc. | 16.23M | 3.88% | 40,816 | 345.00K |
| 477 | KPRX | Kiora Pharmaceuticals, Inc. | 16.16M | 0.40% | 1,464 | 20.00K |
| 478 | PTN | Palatin Technologies, Inc. | 16.08M | 0.33% | 3,962 | 13.19M |
| 479 | BCDA | BioCardia, Inc. | 16.05M | - | 49,026 | 3.00K |
| 480 | TCRX | TScan Therapeutics, Inc. | 16.04M | 3.68% | 264,826 | 7.11M |
| 481 | ACTU | Actuate Therapeutics, Inc. | 15.72M | -3.56% | 153,494 | - |
| 482 | RADX | Radiopharm Theranostics Limited | 15.35M | 1.80% | 31,627 | 8.90M |
| 483 | KTTA | Pasithea Therapeutics Corp. | 15.04M | 2.09% | 22,979 | - |
| 484 | ICU | SeaStar Medical Holding Corporation | 14.98M | -2.58% | 50,517 | 1.71M |
| 485 | LPCN | Lipocine Inc. | 14.92M | -6.22% | 487,472 | 1.57M |
| 486 | CNSY | Cerenome, Inc. | 14.80M | 8.94% | 36,175 | 4.20M |
| 487 | AEON | AEON Biopharma, Inc. | 14.22M | -8.06% | 1,018,288 | - |
| 488 | HIND | Vyome Holdings, Inc. | 14.18M | -0.49% | 1,970 | 129.73K |
| 489 | TVRD | Tvardi Therapeutics, Inc. | 13.74M | -4.63% | 103,939 | - |
| 490 | CTXR | Citius Pharmaceuticals, Inc. | 13.67M | 1.92% | 44,603 | 7.11M |
| 491 | CLRB | Cellectar Biosciences, Inc. | 13.42M | 1.43% | 36,260 | - |
| 492 | INAB | IN8bio, Inc. | 13.41M | -1.45% | 6,184 | - |
| 493 | KPTI | Karyopharm Therapeutics Inc. | 12.96M | -4.80% | 402,786 | 146.62M |
| 494 | TPST | Tempest Therapeutics, Inc. | 12.57M | -1.29% | 78,624 | - |
| 495 | PLUR | Pluri Inc. | 12.34M | - | 110 | 1.02M |
| 496 | INTS | Intensity Therapeutics, Inc. | 12.21M | 1.63% | 5,841 | - |
| 497 | NIKI | Niki BioSolutions, Inc. | 12.05M | -5.09% | 6,549 | - |
| 498 | BLRX | BioLineRx Ltd. | 11.91M | 1.81% | 5,654 | 1.39M |
| 499 | DARE | Daré Bioscience, Inc. | 11.85M | 0.39% | 46,673 | 1.37M |
| 500 | PASG | Passage Bio, Inc. | 11.71M | -3.70% | 1,374 | - |